Connect your AI

AngioDynamics ANGO Proceeds From Issuance Of Other Long Term Debt

Proceeds From Issuance Of Other Long Term Debt at other companies

MillerKnollMLKN

$17.4M—

Richtech Robotics Inc.RR

$845.75K—

Community Health SystemsCYH

$20M+33.3%

Simmons First NationalSFNC

$430M-50.3%

First Busey CorporationBUSE

$11M-34.0%

Mercado LibreMELI

$21.52B+141%

Other financials

Income statement

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt.

The official record: AngioDynamics’s 10-K, filed July 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's proceeds from issuance of other long term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AngioDynamics's proceeds from issuance of other long term debt?: AngioDynamics (ANGO) reported proceeds from issuance of other long term debt of $0 in Q1 2025.